Oricell Therapeutics completes USD110m pre-IPO financing
Tempus expands oncology collaboration with Gilead to accelerate AI-driven R&D
Gilead to acquire Tubulis to expand ADC oncology capabilities
FDA grants Fast Track status to SIM0505 for platinum‑resistant ovarian cancer
AstraZeneca reports positive Phase III data for Imfinzi and Imjudo in liver cancer
Mary's Medicinals to participate in CMS trial programme with cannabinoid-based wellness products
Thermo Fisher Scientific unveils CHOvantage GS Kit to speed biologics development
Frontier Medicines licenses FMC-220 oncology programme to LG Chem in global deal
Natera study shows Signatera MRD may help select breast cancer patients for non-surgical management
GSK's bepirovirsen accepted for review in China as potential Hepatitis B functional cure
Aurinia Pharmaceuticals agrees to acquire Kezar Life Sciences
GXO appointed to manage NHS England bowel cancer home testing kits